Exempt media are formulations that have historically demonstrated an exceptionally low failure rate when prepared by commercial manufacturers under controlled conditions.

M22-A3 defines clear responsibilities for all parties involved:

Manufacturers of commercially prepared culture media must adhere to stringent manufacturing practices. Under CLSI M22-A3, they are required to:

: Using specific "ATCC" (American Type Culture Collection) control strains to confirm the media supports expected growth.

Even for exempt media, laboratories must still perform visual inspections for contamination, cracked agar, freezing, hemolysis, or excessive drying upon receipt. 2. Non-Exempt Media (Mandatory User Testing)

While many professionals search for a free "CLSI M22-A3 PDF" online, it is important to note that CLSI standards are copyrighted materials. Accessing unauthorized or pirated PDFs poses significant compliance risks, as outdated drafts or corrupted files can lead to laboratory errors during inspection. Legitimate Ways to Access M22-A3:

The official M22-A3 PDF includes invaluable appendices (usually Appendix A, B, C) containing:

Procedures to follow when a medium fails quality control tests. Why Use the CLSI M22-A3 PDF?

In clinical microbiology, the accuracy of diagnostic testing relies heavily on the quality of culture media. To ensure consistency and reliability, laboratories and manufacturers follow strict quality control (QC) guidelines. The definitive standard for this process is the Clinical and Laboratory Standards Institute (CLSI) document , titled "Quality Control of Commercially Prepared Culture Media."